Medicare for all won't work. This might.

12 June 2019 - About 30 million Americans still lack health insurance, and more than 60 million have trouble paying ...

Read more →

Patients, physicians raise concerns with BC biosimilar non-medical switching policy

6 June 2019 - On 27 May, the Government of British Columbia announced a policy that will forcibly switch thousands ...

Read more →

Private insurers are afraid of Medicare for all. They should be excited.

5 June 2019 - Since presidential candidate and U.S. Senator Bernie Sanders announced his “Medicare for All” plan in early ...

Read more →

Could the NHS be part of a US-UK trade deal?

5 June 2019 - Donald Trump sparked concern about the health service’s future but the reality is more complex. ...

Read more →

Trump says UK’s National Health Service not on table in trade talks

5 June 2019 - ‘When you’re dealing in trade everything’s on the table, so NHS or anything else,’ US president said ...

Read more →

US takes aim at the UK’s National Health Service

4 June 2019 - There are fears a US-UK trade deal could open the NHS up for privatisation and raise ...

Read more →

PBM launches oncology biosimilar medical pharmacy initiative

4 June 2019 - Ahead of the anticipated 2019 marketing of FDA-approved anticancer biosimilars in the United States, pharmacy benefit manager ...

Read more →

Hancock says “NHS not for sale” in post-Brexit US trade talks

3 June 2019 - Tensions rise as President Trump arrives for state visit. ...

Read more →

Single payer reform—“Medicare for All”

31 May 2019 - The prospect of single-payer “Medicare-for-all” reform evokes enthusiasm and concern.  ...

Read more →

Canada to limit scope of new drug price rules

29 May 2019 - The federal government has assured the pharmaceutical industry that new features of its plan to cut ...

Read more →

No end in sight to rising drug prices, study finds

1 June 2019 - Researchers say bold bipartisan action is needed to stem the rising cost of popular prescription drugs that ...

Read more →

Chinese policies fail to curb soaring drug prices

2 June 2019 - Power of pharmaceutical monopoly starts with the manufacturing of ingredients. ...

Read more →

The upcoming U.S. health care cost debate — the public’s views

29 May 2019 - More than two thirds (69%) of the U.S. public has said that reducing health care costs should ...

Read more →

Canadian Biosimilars Forum applauds B.C. Government's landmark decision to enhance adoption of biosimilars and calls on remaining provinces to follow

27 May 2019 - The Canadian Biosimilars Forum today commends the Government of British Columbia for taking a decisive step ...

Read more →

BC PharmaCare’s Biosimilars Initiative an important step towards improving patient access to safe and effective medicines

27 May 2019 - Biosimilars Initiative implementation could contribute to significant cost savings for the BC health care system. ...

Read more →